human mesothelin d9r5g antibody (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
93
Structured Review
Cell Signaling Technology Inc
human mesothelin d9r5g antibody
Human Mesothelin D9r5g Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+mesothelin+d9r5g+antibody/Mesothelin+XP+Rabbit+mAb/10__1016_slash_j__nucmedbio__2025__109051-115-11-15
Average 93 stars, based on 13 article reviews
Human Mesothelin D9r5g Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+mesothelin+d9r5g+antibody/Mesothelin+XP+Rabbit+mAb/10__1016_slash_j__nucmedbio__2025__109051-115-11-15
Average 93 stars, based on 13 article reviews
human mesothelin d9r5g antibody - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Expressing:Article Title: ImmunoPET for mesothelin positive tissues using bio-orthogonal in-vivo click chemistry Article Snippet: Mesothelin is a membrane bound antigen overexpressed in a wide array of cancers including ovarian, pancreatic, lung, and triple negative breast cancers.. Here a full-length IgG antibody developed against mesothelin, called MESO-HSS1 was conjugated for immunoPET imaging and assessed in-vivo in a H956 mesothelin positive model.. Furthermore, random lysine conjugation as well as a site selective conjugation method were compared in two pretargeting models for overall tumor uptake alongside non target organs and tumor to organ ratios. Western Blot:Article Title: ImmunoPET for mesothelin positive tissues using bio-orthogonal in-vivo click chemistry Article Snippet: Mesothelin is a membrane bound antigen overexpressed in a wide array of cancers including ovarian, pancreatic, lung, and triple negative breast cancers.. Here a full-length IgG antibody developed against mesothelin, called MESO-HSS1 was conjugated for immunoPET imaging and assessed in-vivo in a H956 mesothelin positive model.. Furthermore, random lysine conjugation as well as a site selective conjugation method were compared in two pretargeting models for overall tumor uptake alongside non target organs and tumor to organ ratios. |